.png)
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
BLOG
Read on
%201.png)
Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Revised Annex 1 and the Focus on Microbial Control Strategies
The updates to EU Annex 1 added a great deal of emphasis on microbial control. By performing gap assessments and developing thorough, site-specific...
Starburst Data Rebel Awards: Data Product of the Year
We are proud to announce that Adam Mendez, Head of Data Engineering and Architecture and the Data Platform Team at Resilience, has won the Starburst...
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Are you an innovative company looking for a dependable CDMO partner for your large molecule projects? You have come to the right place.
On-demand Webinar: Optimize research and delivery of complex medicines using data insights
Event Overview: The Life Sciences industry relies on vast amounts of data to rapidly evaluate their novel therapies confidently at a global scale. To...
Scale Your Vaccine Development with Path-to-PAD
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD...
